Molecule Details
InChIKeyGZOSMCIZMLWJML-VJLLXTKPSA-N
Compound NameAbiraterone
Canonical SMILESC[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3cccnc3)=CC[C@@H]12
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Homologous
Avg pChEMBL6.77
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB05812
Drug NameAbiraterone
CAS Number154229-19-3
Groups approved investigational
ATC Codes L01XK52 L02BX53 L02BX03
DescriptionAbiraterone is a potent, irreversible, and selective inhibitor of 17 αhydroxylase/C17,20-lyase (CYP17), an enzyme expressed in testicular, adrenal, and prostatic tumour tissues, to regulate androgen biosynthesis.[A3811, A260880, L40968] Abiraterone was first approved by the FDA and EMA on April,[A26...

Categories: Androstanes Androstenes Antineoplastic Agents Antineoplastic and Immunomodulating Agents Cytochrome P-450 CYP1A2 Inhibitors Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) Cytochrome P-450 CYP2C19 Inhibitors Cytochrome P-450 CYP2C19 inhibitors (strength unknown) Cytochrome P-450 CYP2C8 Inhibitors Cytochrome P-450 CYP2C8 Inhibitors (moderate) Cytochrome P-450 CYP2C9 Inhibitors Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (moderate) Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Inhibitors Cytochrome P-450 CYP3A5 Inhibitors (strength unknown) Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Cytochrome P450 17A1 Inhibitors Endocrine Therapy Enzyme Inhibitors Fused-Ring Compounds Hormone Antagonists Hormone Antagonists and Related Agents Hormones, Hormone Substitutes, and Hormone Antagonists OATP1B1/SLCO1B1 Inhibitors P-glycoprotein inhibitors Poly (ADP-ribose) polymerase (PARP) inhibitors Steroid Synthesis Inhibitors Steroids
Cross-references: BindingDB: 25458 ChEBI: 68642 CHEMBL254328 ChemSpider: 117349 Drugs Product Database (DPD): 20883 D09701 PDB: AER PharmGKB: PA166123407 PubChem:132971 PubChem:175427038 RxCUI: 1100072 Wikipedia: Abiraterone_acetate ZINC: ZINC000003797541
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
P05093 CYP17A1 Homo sapiens Human PF00067 7.1 IC50 ChEMBL;BindingDB
P08684 CYP3A4 Homo sapiens Human PF00067 6.6 IC50 ChEMBL;BindingDB
P08686 CYP21A2 Homo sapiens Human PF00067 6.5 IC50 ChEMBL;BindingDB
DrugBank Target Actions (14)
Target Gene Target Name Action Type
P02763 P02763 Alpha-1-acid glycoprotein 1 binder carriers
P02768 ALB Albumin binder carriers
P05177 CYP1A2 Cytochrome P450 1A2 inhibitor enzymes
P08684 CYP3A4 Cytochrome P450 3A4 inhibitor enzymes
P10632 CYP2C8 Cytochrome P450 2C8 inhibitor enzymes
P10635 CYP2D6 Cytochrome P450 2D6 inhibitor enzymes
P11712 CYP2C9 Cytochrome P450 2C9 inhibitor enzymes
P20815 CYP3A5 Cytochrome P450 3A5 inhibitor enzymes
P33261 CYP2C19 Cytochrome P450 2C19 inhibitor enzymes
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
Q06520 SULT2A1 Sulfotransferase 2A1 substrate enzymes
P05093 CYP17A1 Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor targets
P33527 ABCC1 Multidrug resistance-associated protein 1 inhibitor transporters
Q9Y6L6 SLCO1B1 Solute carrier organic anion transporter family member 1B1 inhibitor transporters